- Home
- IIF vs AMRN Comparison
IIF vs AMRN Comparison
Compare IIF & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIF
- AMRN
- Stock Information
- Founded
- IIF 1993
- AMRN 1989
- Country
- IIF United States
- AMRN Ireland
- Employees
- IIF N/A
- AMRN N/A
- Industry
- IIF Trusts Except Educational Religious and Charitable
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- IIF Finance
- AMRN Health Care
- Exchange
- IIF Nasdaq
- AMRN Nasdaq
- Market Cap
- IIF 230.8M
- AMRN 189.2M
- IPO Year
- IIF N/A
- AMRN 1993
- Fundamental
- Price
- IIF $24.01
- AMRN $0.44
- Analyst Decision
- IIF
- AMRN Buy
- Analyst Count
- IIF 0
- AMRN 1
- Target Price
- IIF N/A
- AMRN N/A
- AVG Volume (30 Days)
- IIF 45.4K
- AMRN 2.1M
- Earning Date
- IIF 01-01-0001
- AMRN 03-12-2025
- Dividend Yield
- IIF 13.94%
- AMRN N/A
- EPS Growth
- IIF N/A
- AMRN N/A
- EPS
- IIF N/A
- AMRN N/A
- Revenue
- IIF N/A
- AMRN $228,614,000.00
- Revenue This Year
- IIF N/A
- AMRN N/A
- Revenue Next Year
- IIF N/A
- AMRN $19.11
- P/E Ratio
- IIF N/A
- AMRN N/A
- Revenue Growth
- IIF N/A
- AMRN N/A
- 52 Week Low
- IIF $18.95
- AMRN $0.35
- 52 Week High
- IIF $24.41
- AMRN $1.11
- Technical
- Relative Strength Index (RSI)
- IIF 50.25
- AMRN 40.65
- Support Level
- IIF $24.21
- AMRN $0.42
- Resistance Level
- IIF $24.59
- AMRN $0.50
- Average True Range (ATR)
- IIF 0.34
- AMRN 0.03
- MACD
- IIF 0.08
- AMRN 0.00
- Stochastic Oscillator
- IIF 55.05
- AMRN 47.27
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.